Hybrid heart fix combines bypass and stents – but study stalls

NCT ID NCT03788369

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at a hybrid approach for treating multiple blocked heart arteries: a minimally invasive bypass for the main artery plus stents for others. Only 6 people took part before the study was stopped early. The goal was to see if this combination is safe and effective in real-world practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Hybrid coronary revascularization (minimally invasive bypass surgery plus stenting)
What this could lead to
If successful, this approach could offer a less invasive alternative to open-heart surgery for people with multiple blocked arteries.
What could go wrong
The study was terminated early and enrolled only 6 people, so results are very limited. The procedure still carries risks like heart attack, stroke, or need for repeat treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY BYPASS GRAFTING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.